294 related articles for article (PubMed ID: 29776930)
1. Modifying the Lantibiotic Mutacin 1140 for Increased Yield, Activity, and Stability.
Geng M; Smith L
Appl Environ Microbiol; 2018 Aug; 84(15):. PubMed ID: 29776930
[TBL] [Abstract][Full Text] [Related]
2. Biosynthesis and transport of the lantibiotic mutacin 1140 produced by Streptococcus mutans.
Escano J; Stauffer B; Brennan J; Bullock M; Smith L
J Bacteriol; 2015 Apr; 197(7):1173-84. PubMed ID: 25605307
[TBL] [Abstract][Full Text] [Related]
3. The leader peptide of mutacin 1140 has distinct structural components compared to related class I lantibiotics.
Escano J; Stauffer B; Brennan J; Bullock M; Smith L
Microbiologyopen; 2014 Dec; 3(6):961-72. PubMed ID: 25400246
[TBL] [Abstract][Full Text] [Related]
4. Carboxyl Analogue of Mutacin 1140, a Scaffold for Lead Antibacterial Discovery.
Escano J; Ravichandran A; Salamat B; Smith L
Appl Environ Microbiol; 2017 Jul; 83(14):. PubMed ID: 28500042
[TBL] [Abstract][Full Text] [Related]
5. Effect of amino acid substitutions in conserved residues in the leader peptide on biosynthesis of the lantibiotic mutacin II.
Chen P; Qi FX; Novak J; Krull RE; Caufield PW
FEMS Microbiol Lett; 2001 Feb; 195(2):139-44. PubMed ID: 11179642
[TBL] [Abstract][Full Text] [Related]
6. Site-directed mutations in the lanthipeptide mutacin 1140.
Chen S; Wilson-Stanford S; Cromwell W; Hillman JD; Guerrero A; Allen CA; Sorg JA; Smith L
Appl Environ Microbiol; 2013 Jul; 79(13):4015-23. PubMed ID: 23603688
[TBL] [Abstract][Full Text] [Related]
7. Blueprints for the rational design of therapeutic mutacin 1140 variants.
Kers JA; Sharp RE; Muley S; Mayo M; Colbeck J; Zhu Y; DeFusco AW; Park JH; Handfield M
Chem Biol Drug Des; 2018 Dec; 92(6):1940-1953. PubMed ID: 30010233
[TBL] [Abstract][Full Text] [Related]
8. Efficacious Analogs of the Lantibiotic Mutacin 1140 against a Systemic Methicillin-Resistant Staphylococcus aureus Infection.
Geng M; Ravichandran A; Escano J; Smith L
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30275083
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of a Novel Lantibiotic Using Mutacin II Biosynthesis Apparatus.
Biswas S
Microbiol Spectr; 2023 Feb; 11(1):e0303022. PubMed ID: 36645288
[TBL] [Abstract][Full Text] [Related]
10. Genetic Analysis of Mutacin B-Ny266, a Lantibiotic Active against Caries Pathogens.
Dufour D; Barbour A; Chan Y; Cheng M; Rahman T; Thorburn M; Stewart C; Finer Y; Gong SG; Lévesque CM
J Bacteriol; 2020 May; 202(12):. PubMed ID: 32229530
[TBL] [Abstract][Full Text] [Related]
11. Structure and dynamics of the lantibiotic mutacin 1140.
Smith L; Zachariah C; Thirumoorthy R; Rocca J; Novák J; Hillman JD; Edison AS
Biochemistry; 2003 Sep; 42(35):10372-84. PubMed ID: 12950164
[TBL] [Abstract][Full Text] [Related]
12. The group I strain of Streptococcus mutans, UA140, produces both the lantibiotic mutacin I and a nonlantibiotic bacteriocin, mutacin IV.
Qi F; Chen P; Caufield PW
Appl Environ Microbiol; 2001 Jan; 67(1):15-21. PubMed ID: 11133423
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity study of the lantibiotic mutacin II from Streptococcus mutans T8 by a gene replacement strategy.
Chen P; Novak J; Kirk M; Barnes S; Qi F; Caufield PW
Appl Environ Microbiol; 1998 Jul; 64(7):2335-40. PubMed ID: 9647795
[TBL] [Abstract][Full Text] [Related]
14. Production, purification, sequencing and activity spectra of mutacins D-123.1 and F-59.1.
Nicolas GG; LaPointe G; Lavoie MC
BMC Microbiol; 2011 Apr; 11():69. PubMed ID: 21477375
[TBL] [Abstract][Full Text] [Related]
15. Sequence analysis of mutA and mutM genes involved in the biosynthesis of the lantibiotic mutacin II in Streptococcus mutans.
Woodruff WA; Novak J; Caufield PW
Gene; 1998 Jan; 206(1):37-43. PubMed ID: 9461412
[TBL] [Abstract][Full Text] [Related]
16. Mutacin H-29B is identical to mutacin II (J-T8).
Nicolas G; Morency H; LaPointe G; Lavoie MC
BMC Microbiol; 2006 Apr; 6():36. PubMed ID: 16626493
[TBL] [Abstract][Full Text] [Related]
17. Genetic and biochemical analysis of mutacin 1140, a lantibiotic from Streptococcus mutans.
Hillman JD; Novák J; Sagura E; Gutierrez JA; Brooks TA; Crowley PJ; Hess M; Azizi A; Leung K; Cvitkovitch D; Bleiweis AS
Infect Immun; 1998 Jun; 66(6):2743-9. PubMed ID: 9596742
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of the antimicrobial mechanism of mutacin 1140.
Smith L; Hasper H; Breukink E; Novak J; Cerkasov J; Hillman JD; Wilson-Stanford S; Orugunty RS
Biochemistry; 2008 Mar; 47(10):3308-14. PubMed ID: 18266322
[TBL] [Abstract][Full Text] [Related]
19. Pseudomycoicidin, a Class II Lantibiotic from Bacillus pseudomycoides.
Basi-Chipalu S; Dischinger J; Josten M; Szekat C; Zweynert A; Sahl HG; Bierbaum G
Appl Environ Microbiol; 2015 May; 81(10):3419-29. PubMed ID: 25769830
[TBL] [Abstract][Full Text] [Related]
20. Purification of mutacin III from group III Streptococcus mutans UA787 and genetic analyses of mutacin III biosynthesis genes.
Qi F; Chen P; Caufield PW
Appl Environ Microbiol; 1999 Sep; 65(9):3880-7. PubMed ID: 10473390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
